ARGENT BIOPHARMA LIMITED ASX News

6 January 2025

Placing to Raise US$4,500,000

Argent BioPharma secures $4.5 million for CNS and immune disorder treatments.

Argent BioPharma Capital Raise Biopharmaceuticals Drug Development Stock Market News

Posted on: 06/01/2025

2 January 2025

Trading Halt

Argent BioPharma halts trading pending a capital raising announcement.

Argent BioPharma Trading Halt Capital Raising ASX Stock Market News

Posted on: 02/01/2025

28 November 2024

ASX Listing Update

Argent BioPharma plans to delist from LSE by December 31, 2024.

Argent BioPharma Delisting London Stock Exchange ASX Biopharmaceutical Industry

Posted on: 28/11/2024

31 October 2024

Quarterly Activities/Appendix 4C Cash Flow Report

Argent BioPharma reports collaboration with SINTEF and voluntary delisting from ASX.

Argent BioPharma Biopharmaceuticals Stock Market News ASX Delisting Corporate Strategy

Posted on: 31/10/2024

29 July 2024

Quarterly Activities/Appendix 4C Cash Flow Report

Argent BioPharma lists on OTCQB and appoints new CFO.

Argent BioPharma OTCQB Listing Stock Market News Biopharmaceuticals

Posted on: 29/07/2024